Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review

Gautam Sethi, Muthu K. Shanmugam, Sudha Warrier, Myriam Merarchi, Frank Arfuso, Alan Prem Kumar, Anupam Bishayee

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Novel and alternative options are being adopted to combat the initiation and progression of human cancers. One of the approaches is the use of molecules isolated from traditional medicinal herbs, edible dietary plants and seeds that play a pivotal role in the prevention/treatment of cancer, either alone or in combination with existing chemotherapeutic agents. Compounds that modulate these oncogenic processes are potential candidates for cancer therapy and may eventually make it to clinical applications. Diosgenin is a naturally occurring steroidal sapogenin and is one of the major bioactive compounds found in dietary fenugreek (Trigonella foenum-graecum) seeds. In addition to being a lactation aid, diosgenin has been shown to be hypocholesterolemic, gastro-and hepato-protective, anti-oxidant, anti-inflammatory, anti-diabetic, and anti-cancer. Diosgenin has a unique structural similarity to estrogen. Several preclinical studies have reported on the pro-apoptotic and anti-cancer properties of diosgenin against a variety of cancers, both in in vitro and in vivo. Diosgenin has also been reported to reverse multi-drug resistance in cancer cells and sensitize cancer cells to standard chemotherapy. Remarkably, diosgenin has also been reported to be used by pharmaceutical companies to synthesize steroidal drugs. Several novel diosgenin analogs and nano-formulations have been synthesized with improved anti-cancer efficacy and pharmacokinetic profile. In this review we discuss in detail the multifaceted anti-cancer properties of diosgenin that have found application in pharmaceutical, functional food, and cosmetic industries; and the various intracellular molecular targets modulated by diosgenin that abrogate the oncogenic process.

Original languageEnglish
Article number645
JournalNutrients
Volume10
Issue number5
DOIs
Publication statusPublished - 19-05-2018

Fingerprint

Diosgenin
diosgenin
neoplasms
Neoplasms
Trigonella
drugs
Seeds
Sapogenins
sapogenins
Trigonella foenum-graecum
Pharmaceutical Preparations
fenugreek
multiple drug resistance
Edible Plants
Functional Food
cosmetics
Food Industry
seeds
Multiple Drug Resistance
oxidants

All Science Journal Classification (ASJC) codes

  • Food Science
  • Nutrition and Dietetics

Cite this

Sethi, G., Shanmugam, M. K., Warrier, S., Merarchi, M., Arfuso, F., Kumar, A. P., & Bishayee, A. (2018). Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review. Nutrients, 10(5), [645]. https://doi.org/10.3390/nu10050645
Sethi, Gautam ; Shanmugam, Muthu K. ; Warrier, Sudha ; Merarchi, Myriam ; Arfuso, Frank ; Kumar, Alan Prem ; Bishayee, Anupam. / Pro-apoptotic and anti-cancer properties of diosgenin : A comprehensive and critical review. In: Nutrients. 2018 ; Vol. 10, No. 5.
@article{ea45cb59e8fa43ffa6c2c62fed15148b,
title = "Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review",
abstract = "Novel and alternative options are being adopted to combat the initiation and progression of human cancers. One of the approaches is the use of molecules isolated from traditional medicinal herbs, edible dietary plants and seeds that play a pivotal role in the prevention/treatment of cancer, either alone or in combination with existing chemotherapeutic agents. Compounds that modulate these oncogenic processes are potential candidates for cancer therapy and may eventually make it to clinical applications. Diosgenin is a naturally occurring steroidal sapogenin and is one of the major bioactive compounds found in dietary fenugreek (Trigonella foenum-graecum) seeds. In addition to being a lactation aid, diosgenin has been shown to be hypocholesterolemic, gastro-and hepato-protective, anti-oxidant, anti-inflammatory, anti-diabetic, and anti-cancer. Diosgenin has a unique structural similarity to estrogen. Several preclinical studies have reported on the pro-apoptotic and anti-cancer properties of diosgenin against a variety of cancers, both in in vitro and in vivo. Diosgenin has also been reported to reverse multi-drug resistance in cancer cells and sensitize cancer cells to standard chemotherapy. Remarkably, diosgenin has also been reported to be used by pharmaceutical companies to synthesize steroidal drugs. Several novel diosgenin analogs and nano-formulations have been synthesized with improved anti-cancer efficacy and pharmacokinetic profile. In this review we discuss in detail the multifaceted anti-cancer properties of diosgenin that have found application in pharmaceutical, functional food, and cosmetic industries; and the various intracellular molecular targets modulated by diosgenin that abrogate the oncogenic process.",
author = "Gautam Sethi and Shanmugam, {Muthu K.} and Sudha Warrier and Myriam Merarchi and Frank Arfuso and Kumar, {Alan Prem} and Anupam Bishayee",
year = "2018",
month = "5",
day = "19",
doi = "10.3390/nu10050645",
language = "English",
volume = "10",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

Sethi, G, Shanmugam, MK, Warrier, S, Merarchi, M, Arfuso, F, Kumar, AP & Bishayee, A 2018, 'Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review', Nutrients, vol. 10, no. 5, 645. https://doi.org/10.3390/nu10050645

Pro-apoptotic and anti-cancer properties of diosgenin : A comprehensive and critical review. / Sethi, Gautam; Shanmugam, Muthu K.; Warrier, Sudha; Merarchi, Myriam; Arfuso, Frank; Kumar, Alan Prem; Bishayee, Anupam.

In: Nutrients, Vol. 10, No. 5, 645, 19.05.2018.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pro-apoptotic and anti-cancer properties of diosgenin

T2 - A comprehensive and critical review

AU - Sethi, Gautam

AU - Shanmugam, Muthu K.

AU - Warrier, Sudha

AU - Merarchi, Myriam

AU - Arfuso, Frank

AU - Kumar, Alan Prem

AU - Bishayee, Anupam

PY - 2018/5/19

Y1 - 2018/5/19

N2 - Novel and alternative options are being adopted to combat the initiation and progression of human cancers. One of the approaches is the use of molecules isolated from traditional medicinal herbs, edible dietary plants and seeds that play a pivotal role in the prevention/treatment of cancer, either alone or in combination with existing chemotherapeutic agents. Compounds that modulate these oncogenic processes are potential candidates for cancer therapy and may eventually make it to clinical applications. Diosgenin is a naturally occurring steroidal sapogenin and is one of the major bioactive compounds found in dietary fenugreek (Trigonella foenum-graecum) seeds. In addition to being a lactation aid, diosgenin has been shown to be hypocholesterolemic, gastro-and hepato-protective, anti-oxidant, anti-inflammatory, anti-diabetic, and anti-cancer. Diosgenin has a unique structural similarity to estrogen. Several preclinical studies have reported on the pro-apoptotic and anti-cancer properties of diosgenin against a variety of cancers, both in in vitro and in vivo. Diosgenin has also been reported to reverse multi-drug resistance in cancer cells and sensitize cancer cells to standard chemotherapy. Remarkably, diosgenin has also been reported to be used by pharmaceutical companies to synthesize steroidal drugs. Several novel diosgenin analogs and nano-formulations have been synthesized with improved anti-cancer efficacy and pharmacokinetic profile. In this review we discuss in detail the multifaceted anti-cancer properties of diosgenin that have found application in pharmaceutical, functional food, and cosmetic industries; and the various intracellular molecular targets modulated by diosgenin that abrogate the oncogenic process.

AB - Novel and alternative options are being adopted to combat the initiation and progression of human cancers. One of the approaches is the use of molecules isolated from traditional medicinal herbs, edible dietary plants and seeds that play a pivotal role in the prevention/treatment of cancer, either alone or in combination with existing chemotherapeutic agents. Compounds that modulate these oncogenic processes are potential candidates for cancer therapy and may eventually make it to clinical applications. Diosgenin is a naturally occurring steroidal sapogenin and is one of the major bioactive compounds found in dietary fenugreek (Trigonella foenum-graecum) seeds. In addition to being a lactation aid, diosgenin has been shown to be hypocholesterolemic, gastro-and hepato-protective, anti-oxidant, anti-inflammatory, anti-diabetic, and anti-cancer. Diosgenin has a unique structural similarity to estrogen. Several preclinical studies have reported on the pro-apoptotic and anti-cancer properties of diosgenin against a variety of cancers, both in in vitro and in vivo. Diosgenin has also been reported to reverse multi-drug resistance in cancer cells and sensitize cancer cells to standard chemotherapy. Remarkably, diosgenin has also been reported to be used by pharmaceutical companies to synthesize steroidal drugs. Several novel diosgenin analogs and nano-formulations have been synthesized with improved anti-cancer efficacy and pharmacokinetic profile. In this review we discuss in detail the multifaceted anti-cancer properties of diosgenin that have found application in pharmaceutical, functional food, and cosmetic industries; and the various intracellular molecular targets modulated by diosgenin that abrogate the oncogenic process.

UR - http://www.scopus.com/inward/record.url?scp=85047336735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047336735&partnerID=8YFLogxK

U2 - 10.3390/nu10050645

DO - 10.3390/nu10050645

M3 - Review article

AN - SCOPUS:85047336735

VL - 10

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 5

M1 - 645

ER -